🇺🇸 Desloratadine 5 mg in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Epilepsy — 2 reports (15.38%)
  2. Malaise — 2 reports (15.38%)
  3. Pyrexia — 2 reports (15.38%)
  4. Acute Coronary Syndrome — 1 report (7.69%)
  5. Aggression — 1 report (7.69%)
  6. Anaphylactic Shock — 1 report (7.69%)
  7. Chills — 1 report (7.69%)
  8. Confusional State — 1 report (7.69%)
  9. Disorientation — 1 report (7.69%)
  10. Disturbance In Attention — 1 report (7.69%)

Source database →

Desloratadine 5 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Desloratadine 5 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Desloratadine 5 mg in United States?

Organon and Co is the originator. The local marketing authorisation holder may differ — check the official source linked above.